Disease

HIV Therapy: Safer, simpler and longer-lasting

  • December, 06 2019
  • 22

World AIDS day on Sunday, December 1 drew attention to the 38 million people still living with the human immunodeficiency virus (HIV), and the over 777,000 deaths claimed in 2018 by the virus. But there is lots of good news, too. Well over half of those w

Disease

Immunotherapies battle for lead in lung cancer

  • November, 13 2019
  • 127

Much of the buzz in lung cancer is around new immunotherapy combinations – and whether recent data from Bristol Myers Squibb will allow it to regain ground from market-leader Merck, whose Keytruda (pembrolizumab) continues to lead the pack.   B

Related Videos
Oliver Spray Analyst
Oliver Spray Analyst

M&A Outlook for 2018

Amanda Mucklus Analyst
Amanda Mucklus Analyst

Diversification Strategy

Pharma Intelligence
Pharma Intelligence

Biosimilars Battlegrounds

Pharma Intelligence
Pharma Intelligence

Q4 2018 Outlook Webinar